All Effectiveness Bank analyses to date of documents related to use and problem use of illegal drugs starting with the analyses most recently added or updated, totalling today 815 documents.
Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
REVIEW 2019 HTM file
The effectiveness of residential treatment services for individuals with substance use disorders: a systematic review
de Andrade D., Elphinston R.A., Quinn C. et al.
Drug and Alcohol Dependence: 2019, 201, p. 227–235.
Has enough high-quality evidence accumulated over the past five years to improve confidence in the effectiveness of residential treatment?
Bailey K., Trevillion K., Gilchrist G.
Addiction Research and Theory: 2019, p. 1–9.
Within treatment systems that have tended to underestimate or overlook the importance of ‘trauma-informed’ practice, this study explores how practitioners in England respond to the needs of women with substance use problems, histories of abuse, and symptoms of post-traumatic stress disorder.
STUDY 2019 HTM file
Capital depreciation: the lack of recovery capital and post-release support for prisoners leaving the Drug Recovery Wings in England and Wales
Lloyd C., Page G., McKeganey N. et al.
International Journal of Drug Policy: 2019, 70, p. 107–116.
While drug recovery wings were specifically designed to facilitate recovery from drug and alcohol problems among prisoners, this small study found that the sharp drop-off in support when they returned to the community ended many recovery journeys prematurely.
REVIEW 2015 HTM file
The effectiveness and cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs: a systematic review and economic evaluation
Hayhurst K.P., Leitner M., Davies L. et al.
Health Technology Assessment: 2015, 19(6).
Although diversionary schemes continue to be a strategic focus for policy in relation to tackling drug-related problems, UK review finds that the evidence base for the effectiveness of these schemes is lacking.
REVIEW 2017 HTM file
Screening, brief intervention, and referral to treatment for opioid and other substance use during infertility treatment
Wright T.E.
Fertility and Sterility: 2017, 108(2), p. 214–221.
How can infertility specialists integrate screening, brief intervention, and referral to treatment into their everyday practice?
STUDY 2018 HTM file
New psychoactive substances: new service provider challenges
Ralphs R., Gray P.
Drugs: Education, Prevention and Policy: 2018, 25(4), p. 301–312.
How can the UK develop an effective treatment response to new psychoactive substances?
STUDY 2016 HTM file
Establishing a ‘Corstonian’ continuous care pathway for drug using female prisoners: Linking drug recovery wings and women’s community services
Grace S., Page G., Lloyd C., et al.
Criminology and Criminal Justice: 2016, 16(5), p. 602–621.
How do drug recovery wings in women’s prisons compare with best practice in Baroness Corston’s 2007 report to the Home Office?
Marsden J., Stillwell G., James K. et al.
Lancet Psychiatry: 2019, 6, p. 391–402.
Instead of a set programme, a clinic in London tried offering methadone or buprenorphine patients still using heroin or cocaine a selection from a suite of well-supported psychological interventions tailored to the patient and then systematically re-tailored in the light of how they responded. It worked – but did it work well enough, and would the findings be replicated in more typical circumstances?
STUDY 2010 HTM file
Preventing drug abuse among adolescent girls: outcome data from an internet-based intervention
Schwinn T.M., Schinke S.P., Di Noia J.
Prevention Science: 2010, 11, p. 24–32.
In this US study a substance use prevention programme for adolescent girls accessed over the internet from home had effects comparable to school-based drug education, yet occupied no classroom or teacher time and could inexpensively be replicated across the internet-linked population. Also described are later reports from similar studies.
STUDY 2019 HTM file
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Haight B.R., Learned S.M., Laffont C.M. et al.
Lancet: 2019, 393, p. 778–790.
In the new form of extended-release injections with effects lasting a month, the opioid medication buprenorphine was found to suppress illegal opioid use more effectively than a placebo, reinforcing its promise as a possible “game-changer” in opiate addiction treatment.
Select search results page
PREVIOUS | NEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82